The measurement of the biomarker for diagnosis of th retinopathy of prematurity
Not Applicable
- Conditions
- Retinopathy of prematurity
- Registration Number
- JPRN-UMIN000022720
- Lead Sponsor
- Tokyo Metropolitan children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.neonate with chromosomal anomaly 2.neonate with multiple malformation 3.neonate with ophthalmogic abnormality 4.neonate who is judged to be inappropriate as sublect.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We examine relations between tryptase level and onset of the retinopahy of prematurity.
- Secondary Outcome Measures
Name Time Method 1.We examine relations between tryptase level and gestational age and birth weight. 2.Postnatal change of the tryptase level. 3.We examine relations between tryptase level and severity of the retinopathy of prematurity.